Manufacturer record
Magnatek Enterprises: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Magnatek Enterprises (Himachal Pradesh) were declared Not of Standard Quality between January 2024 and February 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: MBT-22012, Cefodoxime Proxetil and Potassium Clavulanate Tablets (exp Sep 2023). RDTL Chandigarh (state lab) found it not of standard quality: Assay of Potassium Clavulanate Diluted calculated as Clavulanic Acid. Listed in the February 2024 alert.
Records by type
2 records linked to Magnatek Enterprises in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Cefodoxime Proxetil and Potassium Clavulanate Tablets | Batch MBT-22012Mfg Jun 2022 · Exp Sep 2023 | Assay of Potassium Clavulanate Diluted calculated as Clavulanic AcidAssay | RDTL ChandigarhState lab | Feb 2024 |
| Glimepiride, Pioglitazone and Metformin (PR) Tablets (GLEM- GMP2 Tablets) | Batch MPT-22149Mfg Sep 2022 · Exp Aug 2024 | Identification and Assay of Pioglitazone Hydrochloride calculated as PioglitazoneAssay | RDTL ChandigarhState lab | Jan 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.